News – Page 48 – Endpoints News

Sionna inks $191M IPO for cystic fibrosis pipeline as Aardvark eyes $89M for its own listing

4 months ago

Roche heads to FDA with Gazyva results in a form of lupus

4 months ago

Less than two years after blockbuster IPO, Acelyrin merges with Alumis to combine cash, assets

4 months ago

Bristol Myers prunes pipeline amid new round of cost cuts

4 months ago

Updated: Hospital group blasts proposed 340B rebate models, requests to join lawsuits with HHS

4 months ago

Digital health dealmaking is heating up

4 months ago

AstraZeneca cuts UK funding pledge; Viking says it has ‘enough’ API for trials

4 months ago

AstraZeneca takes $753M charge on abandoned complement drug from Alexion deal

4 months ago

J&J, Intra-Cellular quickly sealed $14B deal as three others passed on buying the neuro drugmaker

4 months ago

AffyImmune’s layoffs; Henlius makes a biosimilar deal with Dr. Reddy’s

4 months ago

Pfizer hires Novartis oncology exec to steer its cancer ambitions

4 months ago

Exclusive: Employer healthcare company Personify Health says it has $500M+ in revenue, is 'highly' profitable

4 months ago

AstraZeneca offers some detail on China probe, reaffirms commitment to that market

4 months ago

Updated: Lilly posts 45% sales jump, culls four programs across obesity, Alzheimer's, heart failure and eczema

4 months ago

Bristol Myers launches fresh round of major cost cuts in bid to get ahead of patent cliff

4 months ago

Teladoc to buy Catapult Health for $65M

4 months ago

Kura's AML drug passes key study in advanced patients, plans next steps with FDA and newly diagnosed studies

4 months ago

Novo Nordisk is feeling the competition from compounded GLP-1s, exec says

4 months ago

Small personalized vaccine trial sees progress in late-stage kidney cancer

4 months ago

Revance and Crown are almost ready to close their deal after earlier bidding war

4 months ago

Bristol Myers, Kyowa Kirin disclose layoffs

4 months ago

EyePoint shares more mid-stage data for therapy trying to compete with Regeneron's Eylea

4 months ago

With first drug now in the clinic, Alys eyes megaround for rest of pipeline

4 months ago

GSK defiant against vaccine challenges, will prioritize other growth areas

4 months ago

First page Previous page 45 46 474849 50 51 Next page Last page